Cadet B, Bhutta S, Mahmoudzadeh S, Merisier M, Shah N. When Overdose of Doxylamine Leads to Severe Rhabdomyolysis and Renal Failure That Requires Hemodialysis: A Case Report and Literature Review. Cureus. 2023;15(8):e43395. doi:10.7759/cureus.43395
Publications
Iatrou A, Daskalakis NP. Unraveling the cell-type-specific molecular pathways of PTSD: integrating GWAS with brain genomic profiling and in vitro modeling. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2023. doi:10.1038/s41386-023-01698-x
Amariuta T, Siewert-Rocks K, Price AL. Modeling tissue co-regulation estimates tissue-specific contributions to disease. Nature genetics. 2023. doi:10.1038/s41588-023-01474-z
Steier Z, Aylard DA, McIntyre LL, et al. Single-cell multiomic analysis of thymocyte development reveals drivers of CD4 T cell and CD8 T cell lineage commitment. Nature immunology. 2023. doi:10.1038/s41590-023-01584-0
Morrill K, Chen F, Karlsson E. Comparative neurogenetics of dog behavior complements efforts towards human neuropsychiatric genetics. Human genetics. 2023. doi:10.1007/s00439-023-02580-y
Blum SM, Rouhani SJ, Sullivan RJ. Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses. Immunological reviews. 2023. doi:10.1111/imr.13262
Rueda-Carrasco J, Sokolova D, Lee SE, et al. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer’s disease models. The EMBO journal. 2023:e113246. doi:10.15252/embj.2022113246
Zwaig M, Johnston MJ, J Y Lee J, et al. Linked-read based analysis of the medulloblastoma genome. Frontiers in oncology. 2023;13:1221611. doi:10.3389/fonc.2023.1221611
Liew MY, Mathews JI, Li A, et al. Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study. Open forum infectious diseases. 2023;10(8):ofad369. doi:10.1093/ofid/ofad369
González-Prieto C, Lynch JP, Lesser CF. PROTEcT, engineered Escherichia coli for the targeted delivery of therapeutics. Trends in molecular medicine. 2023. doi:10.1016/j.molmed.2023.07.007